A detailed history of Baader Bank Aktiengesellschaft transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Baader Bank Aktiengesellschaft holds 119,207 shares of EW stock, worth $7.94 Million. This represents 0.73% of its overall portfolio holdings.

Number of Shares
119,207
Previous 144,065 17.25%
Holding current value
$7.94 Million
Previous $13.8 Million 20.01%
% of portfolio
0.73%
Previous 1.03%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 17, 2024

SELL
$84.3 - $94.31 $2.1 Million - $2.34 Million
-24,858 Reduced 17.25%
119,207 $11 Million
Q1 2024

May 03, 2024

SELL
$72.54 - $95.56 $1.2 Million - $1.58 Million
-16,486 Reduced 10.27%
144,065 $13.8 Million
Q4 2023

Feb 08, 2024

BUY
$61.71 - $77.76 $1.2 Million - $1.51 Million
19,455 Added 13.79%
160,551 $12.2 Million
Q3 2023

Nov 14, 2023

BUY
$69.28 - $93.38 $230,979 - $311,328
3,334 Added 2.42%
141,096 $9.78 Million
Q2 2023

Aug 11, 2023

BUY
$81.41 - $94.33 $652,175 - $755,677
8,011 Added 6.17%
137,762 $13 Million
Q1 2023

May 15, 2023

SELL
$74.26 - $84.51 $213,571 - $243,050
-2,876 Reduced 2.17%
129,751 $10.7 Million
Q4 2022

Feb 14, 2023

BUY
$68.3 - $87.44 $2.59 Million - $3.31 Million
37,849 Added 39.93%
132,627 $9.9 Million
Q3 2022

May 04, 2023

SELL
$82.37 - $107.29 $3.12 Million - $4.06 Million
-37,849 Reduced 28.54%
94,778 $7.83 Million
Q3 2022

Nov 14, 2022

BUY
$82.37 - $107.29 $6.48 Million - $8.45 Million
78,728 Added 490.52%
94,778 $7.83 Million
Q2 2022

Aug 11, 2022

SELL
$86.5 - $128.27 $626,000 - $928,289
-7,237 Reduced 31.08%
16,050 $1.53 Million
Q1 2022

May 18, 2022

BUY
$101.96 - $128.34 $40,784 - $51,336
400 Added 1.75%
23,287 $2.74 Million
Q4 2021

May 17, 2022

BUY
$106.37 - $130.68 $2.43 Million - $2.99 Million
22,887 New
22,887 $2.97 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.2B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Baader Bank Aktiengesellschaft Portfolio

Follow Baader Bank Aktiengesellschaft and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baader Bank Aktiengesellschaft, based on Form 13F filings with the SEC.

News

Stay updated on Baader Bank Aktiengesellschaft with notifications on news.